S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Semiconductor Giants: Navigating the Recent Pullback
3 Key Stocks Helping to Drive the EV Race
Breakout Alert: Coinbase's Consolidation Is About To End
You Can Follow BlackRock’s Market View for Your Money
Closing prices for crude oil, gold and other commodities
JPMorgan Chase Falls 5% as Consumer Cracking Begins to Show
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Semiconductor Giants: Navigating the Recent Pullback
3 Key Stocks Helping to Drive the EV Race
Breakout Alert: Coinbase's Consolidation Is About To End
You Can Follow BlackRock’s Market View for Your Money
Closing prices for crude oil, gold and other commodities
JPMorgan Chase Falls 5% as Consumer Cracking Begins to Show
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Semiconductor Giants: Navigating the Recent Pullback
3 Key Stocks Helping to Drive the EV Race
Breakout Alert: Coinbase's Consolidation Is About To End
You Can Follow BlackRock’s Market View for Your Money
Closing prices for crude oil, gold and other commodities
JPMorgan Chase Falls 5% as Consumer Cracking Begins to Show
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Semiconductor Giants: Navigating the Recent Pullback
3 Key Stocks Helping to Drive the EV Race
Breakout Alert: Coinbase's Consolidation Is About To End
You Can Follow BlackRock’s Market View for Your Money
Closing prices for crude oil, gold and other commodities
JPMorgan Chase Falls 5% as Consumer Cracking Begins to Show
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024

CymaBay Therapeutics (CBAY) Earnings Date, Estimates & Call Transcripts

$32.48
0.00 (0.00%)
(As of 04/1/2024)

Earnings Summary

Upcoming
Earnings Date
May. 20Estimated
Actual EPS
(Feb. 28)
-$0.35 Missed By -$0.04
Consensus EPS
(Feb. 28)
-$0.31
Skip Charts & View Estimated and Actual Earnings Data

CBAY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CBAY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

CymaBay Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20243($0.35)($0.23)($0.30)
Q2 20243($0.40)($0.24)($0.34)
Q3 20243($0.47)($0.24)($0.38)
Q4 20243($0.53)($0.24)($0.38)
FY 202412($1.75)($0.95)($1.41)

CBAY Earnings Date and Information

CymaBay Therapeutics last announced its quarterly earnings results on February 28th, 2024. The biopharmaceutical company reported ($0.35) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.31) by $0.04. The business had revenue of $0.06 million for the quarter, compared to analyst estimates of $0.42 million. CymaBay Therapeutics has generated ($0.97) earnings per share over the last year (($0.97) diluted earnings per share). Earnings for CymaBay Therapeutics are expected to grow in the coming year, from ($1.38) to ($1.37) per share. CymaBay Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off prior year's report dates.

CymaBay Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/20/2024
Estimated)
------- 
2/28/2024Q4 2023($0.31)($0.35)($0.04)($0.35)$0.42 million$0.06 million
11/7/2023Q3 2023($0.30)($0.32)($0.02)($0.32)$0.22 million-    
8/10/2023Q2 2023($0.21)($0.01)+$0.20($0.01)$30.78 million$31.02 million    
5/15/2023Q1 2023($0.16)($0.29)($0.13)($0.29)--
3/16/2023Q4 2022($0.30)($0.30)-($0.30)--    
11/14/2022Q3 2022($0.30)($0.28)+$0.02($0.28)--
8/11/2022Q2 2022($0.30)($0.31)($0.01)($0.31)--    
5/12/2022Q1 2022($0.31)($0.32)($0.01)($0.32)--    
3/17/2022Q4 2021($0.36)($0.34)+$0.02($0.34)--    
11/10/2021Q3 2021($0.26)($0.33)($0.07)($0.33)--  
8/12/2021Q2 2021($0.27)($0.34)($0.07)($0.34)--    
5/13/2021Q1 2021($0.24)($0.25)($0.01)($0.25)--  

CymaBay Therapeutics Earnings - Frequently Asked Questions

When is CymaBay Therapeutics's earnings date?

CymaBay Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off last year's report dates. Learn more on CBAY's earnings history.

Did CymaBay Therapeutics beat their earnings estimates last quarter?

In the previous quarter, CymaBay Therapeutics (NASDAQ:CBAY) missed the analysts' consensus estimate of ($0.31) by $0.04 with a reported earnings per share (EPS) of ($0.35). Learn more on analysts' earnings estimate vs. CBAY's actual earnings.

How much revenue does CymaBay Therapeutics generate each year?

CymaBay Therapeutics (NASDAQ:CBAY) has a recorded annual revenue of $31.07 million.

How much profit does CymaBay Therapeutics generate each year?

CymaBay Therapeutics (NASDAQ:CBAY) has a recorded net income of -$105.37 million. CBAY has generated -$0.97 earnings per share over the last four quarters.

What is CymaBay Therapeutics's EPS forecast for next year?

CymaBay Therapeutics's earnings are expected to grow from ($1.38) per share to ($1.37) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:CBAY) was last updated on 4/13/2024 by MarketBeat.com Staff

From Our Partners